Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

NewAmsterdam Pharma B.V.
Sponsor

NewAmsterdam Pharma B.V.

The Netherlands Gooimeer 2/35, 1411 DC Naarden, The Netherlands

About the sponsor

NewAmsterdam Pharma B.V. focuses on clinical research in atherosclerotic cardiovascular disease, with attention to coronary artery plaque burden, arterial narrowing, and broader cardiovascular risk in adults receiving lipid-lowering treatment.

  • Atherosclerotic cardiovascular disease
  • Coronary atherosclerosis
  • Non-calcified plaque

The sponsor’s studies include outcomes related to coronary plaque characteristics and the progression of atherosclerotic heart and blood vessel disease.

About Specializations

NewAmsterdam Pharma B.V. runs clinical trials in conditions such as Arteriosclerosis, Type 2 diabetes mellitus, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

3 clinical trials

Arteriosclerosis

Recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Ezetimibe
  • Sponsor:NewAmsterdam Pharma B.V.

Type 2 diabetes mellitus

Recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Ezetimibe
  • Sponsor:NewAmsterdam Pharma B.V.

Arteriosclerosis

Not recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Obicetrapib
  • Sponsor:NewAmsterdam Pharma B.V.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.